Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer. Laine M, Greene ME, Kurleto JD, Bozek G, et al. Breast Cancer Res 2024;26:95.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Laine M, Greene ME, Kurleto JD, Bozek G, et al. Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer. Breast Cancer Res 2024;26:95.
PMID: 38849889